Page 227 - Tata_Chemicals_yearly-reports-2021-22
P. 227

01   INTEGRATED      73  STATUTORY      178  FINANCIAL
                                                          STATEMENTS
                                      REPORTS
                  REPORT
                                                          Standalone

            23.  Revenue from operations
                                                                                                       ` in crore
                                                                                       Year ended    Year ended
             Particulars
                                                                                   March 31, 2022  March 31, 2021
             (a)   Sales of products (footnote 'i' and 'ii')                             3,707.47       2,984.26
             (b)  Other operating revenues
                 (i)   Sale of scrap and others                                            13.46          14.62
                                                                                         3,720.93      2,998.88
             Footnotes:
             (i)   Reconciliation of sales of products
                 Revenue from contracts with customer                                    3,809.27       3,121.62
                 Adjustments made to contract price on account of
                 (a)   Discounts / rebates / incentives                                  (101.80)       (137.36)
                                                                                         3,707.47      2,984.26
            (ii)  For operating segments revenue, geographical segments revenue, revenue from major products and revenue from major customers
                (note 35.1).

            24.  Other income
                                                                                                       ` in crore
                                                                                       Year ended    Year ended
             Particulars
                                                                                   March 31, 2022  March 31, 2021
             (a)  Dividend income from
                 (i)   Non-current investments in
                     -   Subsidiaries                                                      29.20          26.33
                     -   Joint venture                                                     27.87          26.49
                     -   other non-current investments measured at FVTOCI                  25.88          20.09
                                                                                           82.95         72.91
             (b)  Interest (finance income)
                 (i)   On bank deposits (financial assets at amortised cost)               19.38          29.49
                 (ii)   On loans and advances (financial assets at amortised cost)          0.02           0.03
                 (iii)  Other interest (financial assets at FVTPL)                         15.19          17.82
                                                                                           34.59         47.34
             (c)  Interest on refund of taxes                                              75.82          18.42
             (d)  Others
                 (i)   Corporate guarantee commission                                       4.54           6.00
                 (ii)   Gain on sale/redemption of investments (net)                       45.85          45.82
                 (iii)  Foreign exchange gain (net)                                         5.33             -
                 (iv)  Miscellaneous income (footnote 'i')                                 28.85          28.66
                                                                                           84.57         80.48
                                                                                          277.93        219.15
            Footnote:
            (i)   Miscellaneous income primarily includes town income, rent income and liabilities written back.
















                                                                                                           225
   222   223   224   225   226   227   228   229   230   231   232